CNA Financial’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

CNA Financial’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,000	Closed	-$356K	–	197
2022 Q1	$356K	Sell	3,000 -2,720	-48%	-$339K	0.11%	167
2021 Q4	$788K	Sell	5,720 -130	-2%	-$16.5K	0.21%	128
2021 Q3	$813K	Sell	5,850 -1,990	-25%	-$248K	0.22%	129
2021 Q2	$761K	Sell	7,840 -890	-10%	-$72.2K	0.22%	137
2021 Q1	$597K	Buy	8,730 +1,470	+20%	+$119K	0.18%	148
2020 Q4	$622K	Sell	7,260 -1,300	-15%	-$110K	0.2%	144
2020 Q3	$556K	Buy	8,560 +1,570	+22%	+$103K	0.2%	120
2020 Q2	$511K	Buy	+6,990	New	+$372K	0.2%	119

Other funds holding BHVN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CNA Financial's BHVN Position: Q2 2022 in Review

CNA Financial sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q2 2022, closing a stake of 3,000 shares — an estimated $356K sold.

CNA Financial first reported a position in BHVN in Q2 2020 and held it in 8 quarters. The position peaked at $813K in Q3 2021. 329 funds tracked by Wall St. Rank hold BHVN as of Q2 2022.

CNA Financial reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q2 2022 after selling out during the quarter.
CNA Financial sold 3,000 Biohaven Pharmaceutical Holding Company Ltd. shares in Q2 2022, an estimated $356K.
CNA Financial first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2020 and held it in 8 quarters.
CNA Financial's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $813K in Q3 2021.
329 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q2 2022.

Based on CNA Financial's 13F filing for Q2 2022, filed 9 Aug 2022.